Browse Title Index
| Issue | Title | |
| Vol 5, No 3 (2014) | Advances in the management of von Willebrand disease | Abstract PDF (Polish) HTML (Polish) |
| Joanna Zdziarska, Teresa Iwaniec, Jacek Musiał, Aleksander B. Skotnicki | ||
| Vol 6, No 1 (2015) | Advances in the supportive treatment of patients with lymphoid and myeloid malignancies | Abstract PDF (Polish) HTML (Polish) |
| Anna Czyż | ||
| Vol 3, No 1 (2012) | Advances in the therapy of primary myelofibrosis | Abstract PDF (Polish) |
| Tomasz Sacha, Joanna Wącław | ||
| Vol 6, No 1 (2015) | Advances in the treatment of adult patients with acute leukemias | Abstract PDF (Polish) HTML (Polish) |
| Agnieszka Wierzbowska | ||
| Vol 6, No 1 (2015) | Advances in the treatment of patients with hemophilias | Abstract PDF (Polish) HTML (Polish) |
| Jerzy Windyga | ||
| Vol 6, No 1 (2015) | Advances in the treatment of patients with Hodgkin lymphoma | Abstract PDF |
| Tomasz Wróbel | ||
| Vol 6, No 1 (2015) | Advances in therapy of patients with chronic myelogenous leukemia | Abstract PDF (Polish) HTML (Polish) |
| Tomasz Sacha, Joanna Wącław | ||
| Vol 6, No 1 (2015) | Advances in transplantation of hematopoietic stem cells from haploidentical donors | Abstract PDF (Polish) HTML (Polish) |
| Kazimierz Hałaburda | ||
| Vol 12, No 3-4 (2021) | Adverse events of monoclonal antibodies use in therapy of hematological malignancies | Abstract PDF |
| Marcela Maksymowicz, Monika Podhorecka | ||
| Vol 3, No 1 (2012) | Allogeneic hematopoietic stem cell transplantation for the treatment of patients with acute myeloid leukemia. Indications and procedural aspects according to the European study groups | Abstract PDF (Polish) |
| Sebastian Giebel, Jacek Najda | ||
| Vol 8, No 2 (2017) | Allogeneic hematopoietic stem cell transplantation for treating patients with myelofibrosis | Abstract PDF (Polish) HTML (Polish) |
| Elżbieta Patkowska, Joanna Góra-Tybor | ||
| Vol 2, No 3 (2011) | Allogeneic hematopoietic stem cell transplantation in treatment of patients with acute myeloid leukemia | Abstract PDF (Polish) |
| Lidia Gil | ||
| Vol 9, No 2 (2018) | Alterations of epigenetic mechanisms in acute myeloid leukemia | Abstract PDF (Polish) |
| Kamil Wiśniewski, Emilia Białopiotrowicz, Joanna Góra-Tybor | ||
| Vol 9, No 4 (2018) | Amyloidosis of the urinary bladder — case report and literature review | Abstract PDF (Polish) |
| Anna Suska, Dorota Rowczenio, Janusz Jaszczyński, Wojciech Szot, Sarah Goldman-Mazur, Artur Jurczyszyn | ||
| Vol 11, No 1 (2020) | Anemia in cancer patients — Expert Group recommendations. Revision 2020 | Abstract PDF (Polish) |
| Piotr Radziwon, Maciej Krzakowski, Ewa Kalinka, Renata Zaucha, Piotr Wysocki, Dariusz Kowalski, Jerzy Gryglewicz, Marek Z. Wojtukiewicz | ||
| Vol 3, No 3 (2012) | Antifungal prophylaxis in patients with hematologic malignancies | Abstract PDF (Polish) |
| Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 14 (2023): Continuous Publishing | Antithrombotic prophylaxis in patients treated with Bruton’s tyrosine kinase inhibitors | Abstract PDF |
| Sebastian Szmit | ||
| Vol 6, No 4 (2015) | Appendix 1. Opinion to evaluate the necessity and conditions required in merging the Maria Sklodowska-Curie Memorial Centre for Oncology — Institute with the Institute of Hematology and Transfusion Medicine, as issued by a Working Committee | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | Appendix 10. A report of a representation made by the Polish Minister of Health, Marian Zembala, during an extraordinary convened at the Scientific Council of the Maria Sklodowska-Curie Memorial Centre for Oncology | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | Appendix 2. Resolution No 14, of the Maria Sklodowska-Curie Memorial Centre for Oncology — Institute’s Scientific Council (26th June 2012) | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | Appendix 3. Resolution No 62, of the Institute of Hematology and Transfusion Medicine’s Scientific Council (10th June 2013), and Resolution No 7, of the Maria Sklodowska-Curie Memorial Centre for Oncology — Institute’s Scientific Council (12th June 2013) | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | Appendix 4. Opinion to evaluate and prepare the conditions under which the Maria Sklodowska-Curie Memorial Centre for Oncology — Institute and the Institute of Hematology and Transfusion Medicine are to be merged | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | Appendix 5. Draft Regulation concerning the Institutes merger intended for creating the Maria Sklodowska-Curie Memorial National Institute of Oncology and Hematology | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | Appendix 6. Open letters from the managements of the Maria Sklodowska-Curie Memorial Centre for Oncology — Institute and Institute of Hematology and Transfusion Medicine | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 4 (2015) | Appendix 7. Call made by the Director of the Chief Council of Research Institutes to the Minister of Health for annulling the separation of the Gliwice branch from within the structures of the Maria Sklodowska-Curie Memorial Centre for Oncology — Institut | Abstract PDF (Polish) |
| Krzysztof Warzocha | ||
| 26 - 50 of 548 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
